| Year |
Citation |
Score |
| 2022 |
Gicana KRB, Pinidmontree C, Kosalathip K, Sirirut S, Komolvanich S, Asawakarn S, Sakcamduang W, Naiyanetr P, Tachampa K. Use of proposed systolic and myocardial performance indices derived from simultaneous ECG and PCG recordings to assess cardiac function in healthy Beagles. Veterinary World. 15: 1785-1797. PMID 36185531 DOI: 10.14202/vetworld.2022.1785-1797 |
0.316 |
|
| 2021 |
Lertwanakarn T, Suntravat M, Sánchez EE, Wolska BM, Solaro RJ, de Tombe PP, Tachampa K. Negative inotropic mechanisms of β-cardiotoxin in cardiomyocytes by depression of myofilament ATPase activity without activation of the classical β-adrenergic pathway. Scientific Reports. 11: 21154. PMID 34707114 DOI: 10.1038/s41598-021-00282-x |
0.429 |
|
| 2020 |
Tachampa K, Wongtawan T. Unique patterns of cardiogenic and fibrotic gene expression in rat cardiac fibroblasts. Veterinary World. 13: 1697-1708. PMID 33061247 DOI: 10.14202/vetworld.2020.1697-1708 |
0.356 |
|
| 2020 |
Lertwanakarn T, Suntravat M, Sanchez EE, Boonhoh W, Solaro RJ, Wolska BM, Martin JL, de Tombe PP, Tachampa K. Suppression of cardiomyocyte functions by β-CTX isolated from the Thai king cobra () venom via an alternative method. The Journal of Venomous Animals and Toxins Including Tropical Diseases. 26: e20200005. PMID 32742278 DOI: 10.1590/1678-9199-Jvatitd-2020-0005 |
0.458 |
|
| 2020 |
Lertwanakarn T, Suntravat M, Sanchez EE, Wolska BM, Solaro RJ, de Tombe P, Tachampa K. Beta-cardiotoxin, a novel compound from king cobra venom, suppresses cardiac function via non-beta-adrenergic pathway. Toxicon : Official Journal of the International Society On Toxinology. 177: S58. PMID 32635097 DOI: 10.1016/J.Toxicon.2019.12.133 |
0.446 |
|
| 2010 |
Biesiadecki BJ, Tachampa K, Yuan C, Jin JP, de Tombe PP, Solaro RJ. Removal of the cardiac troponin I N-terminal extension improves cardiac function in aged mice. The Journal of Biological Chemistry. 285: 19688-98. PMID 20410305 DOI: 10.1074/Jbc.M109.086892 |
0.515 |
|
| 2010 |
de Tombe PP, Mateja RD, Tachampa K, Ait Mou Y, Farman GP, Irving TC. Myofilament length dependent activation. Journal of Molecular and Cellular Cardiology. 48: 851-8. PMID 20053351 DOI: 10.1016/J.Yjmcc.2009.12.017 |
0.446 |
|
| 2010 |
Tachampa K, Wang H, de Tombe PP. Impact of Ischemia/Reperfusion Associated TnI Degradation on Cross-Bridge Dynamics in Skinned Rat Cardiac Trabeculae Biophysical Journal. 98: 356a-357a. DOI: 10.1016/J.Bpj.2009.12.1925 |
0.46 |
|
| 2009 |
Tachampa K, Biesiadecki B, Kobayashi T, Jin J, de Tombe PP. Impact Of N-terminal Truncation Of Cardiac Troponin I On Myofilament Chemo-mechanical Transduction: Implications For The Enhanced Cardiac Function In Hemodynamic Adaptation Biophysical Journal. 96: 502a. DOI: 10.1016/J.Bpj.2008.12.2589 |
0.475 |
|
| 2009 |
Farman GP, Tachampa K, de Tombe PP. Cardiac Troponin I Threonine 144 phosphorylation: impact on myofilament function Biophysical Journal. 96: 501a. DOI: 10.1016/J.Bpj.2008.12.2584 |
0.33 |
|
| 2008 |
Tachampa K, Kobayashi T, Wang H, Martin AF, Biesiadecki BJ, Solaro RJ, de Tombe PP. Increased cross-bridge cycling kinetics after exchange of C-terminal truncated troponin I in skinned rat cardiac muscle. The Journal of Biological Chemistry. 283: 15114-21. PMID 18378675 DOI: 10.1074/Jbc.M801636200 |
0.52 |
|
| 2008 |
Farman GP, Tachampa K, Mateja R, Cazorla O, Lacampagne A, de Tombe PP. Blebbistatin: use as inhibitor of muscle contraction. PflüGers Archiv : European Journal of Physiology. 455: 995-1005. PMID 17994251 DOI: 10.1007/S00424-007-0375-3 |
0.45 |
|
| 2007 |
Tachampa K, Wang H, Farman GP, de Tombe PP. Cardiac troponin I threonine 144: role in myofilament length dependent activation. Circulation Research. 101: 1081-3. PMID 17975107 DOI: 10.1161/Circresaha.107.165258 |
0.488 |
|
| Show low-probability matches. |